According to a Mount Sinai Hospital news release, the hospital’s Department of Population Health Science and Policy at the Icahn School of Medicine will perform an investigational pilot study of a respiratory disease management platform for pediatric asthma patients.
Developed by Cohero Health, the system is seen in two high volume pediatric clinics at the Mount Sinai Health System. Patients will use the platform, which employs connected devices and a game-based mobile app to increase and monitor adherence to asthma medication.
Melissa Manice, PhD, co-founder of Cohero, says, “Cohero is a result of my years of research in chronic respiratory care. Our platform was designed to address the hurdles to proper care and help reduce the overall cost of treating respiratory disease.” The Mount Sinai Hospital news release indicates that the Cohero platform consists of their Hero Tracker sensor that attaches to a medication inhaler to track medication use and syncs wirelessly Cohero’s AsthmaHero mobile application.
In addition to providing real time reports of patient medication use and weekly and monthly summary reports, the app track adherence over time, generates customized reminders and provides a game experience that offers patients in-app and monetary rewards for consistently taking their medication as prescribed. The system also incorporates a mobile spirometer to track clinically relevant lung function measures between office visits.
The pilot study will measure improvements in medication adherence and lung function of patients using Cohero’s platform as compared to a control group, as indicated on the Mount Sinai Hospital news release.
Daniel Seltzer, director of the Center for Technology Innovation and Entrepreneurship at Mount Sinai Health System, states, “Mount Sinai’s work with CoheroHealth demonstrates its commitment to clinical innovation through technology and entrepreneurship.”
Source: Mount Sinai Hospital
